- Home
- ATRA vs BAFN Comparison
ATRA vs BAFN Comparison
Compare ATRA & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- BAFN
- Stock Information
- Founded
- ATRA 2012
- BAFN 1999
- Country
- ATRA United States
- BAFN United States
- Employees
- ATRA N/A
- BAFN N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- BAFN Savings Institutions
- Sector
- ATRA Health Care
- BAFN Finance
- Exchange
- ATRA Nasdaq
- BAFN Nasdaq
- Market Cap
- ATRA 39.7M
- BAFN 70.2M
- IPO Year
- ATRA 2014
- BAFN N/A
- Fundamental
- Price
- ATRA $6.86
- BAFN $17.89
- Analyst Decision
- ATRA Buy
- BAFN
- Analyst Count
- ATRA 6
- BAFN 0
- Target Price
- ATRA $25.70
- BAFN N/A
- AVG Volume (30 Days)
- ATRA 71.1K
- BAFN 7.7K
- Earning Date
- ATRA 03-07-2025
- BAFN 04-24-2025
- Dividend Yield
- ATRA N/A
- BAFN 1.86%
- EPS Growth
- ATRA N/A
- BAFN 134.19
- EPS
- ATRA N/A
- BAFN 2.62
- Revenue
- ATRA $128,940,000.00
- BAFN $83,769,000.00
- Revenue This Year
- ATRA N/A
- BAFN N/A
- Revenue Next Year
- ATRA N/A
- BAFN N/A
- P/E Ratio
- ATRA N/A
- BAFN $6.53
- Revenue Growth
- ATRA 1404.02
- BAFN 10.60
- 52 Week Low
- ATRA $5.40
- BAFN $10.40
- 52 Week High
- ATRA $20.83
- BAFN $19.21
- Technical
- Relative Strength Index (RSI)
- ATRA 41.62
- BAFN 54.31
- Support Level
- ATRA $5.94
- BAFN $17.17
- Resistance Level
- ATRA $7.02
- BAFN $18.39
- Average True Range (ATR)
- ATRA 0.58
- BAFN 0.75
- MACD
- ATRA 0.07
- BAFN -0.25
- Stochastic Oscillator
- ATRA 52.36
- BAFN 37.93
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.